AU6896300A - Vaccines for the treatment of autoimmune disease - Google Patents

Vaccines for the treatment of autoimmune disease

Info

Publication number
AU6896300A
AU6896300A AU68963/00A AU6896300A AU6896300A AU 6896300 A AU6896300 A AU 6896300A AU 68963/00 A AU68963/00 A AU 68963/00A AU 6896300 A AU6896300 A AU 6896300A AU 6896300 A AU6896300 A AU 6896300A
Authority
AU
Australia
Prior art keywords
vaccines
treatment
autoimmune disease
autoimmune
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU68963/00A
Inventor
Simonetta Mocci
Nanette Solvason
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU6896300A publication Critical patent/AU6896300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
AU68963/00A 1999-08-06 2000-08-07 Vaccines for the treatment of autoimmune disease Abandoned AU6896300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14762699P 1999-08-06 1999-08-06
US60147626 1999-08-06
PCT/US2000/021644 WO2001010221A1 (en) 1999-08-06 2000-08-07 Vaccines for the treatment of autoimmune disease

Publications (1)

Publication Number Publication Date
AU6896300A true AU6896300A (en) 2001-03-05

Family

ID=22522280

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68963/00A Abandoned AU6896300A (en) 1999-08-06 2000-08-07 Vaccines for the treatment of autoimmune disease

Country Status (5)

Country Link
EP (1) EP1206190A1 (en)
JP (1) JP2003510335A (en)
AU (1) AU6896300A (en)
CA (1) CA2378285A1 (en)
WO (1) WO2001010221A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030139356A1 (en) 2001-05-18 2003-07-24 Persing David H. Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
MXPA02011486A (en) 2000-05-19 2004-01-26 Corixa Corp Prophylactic and therapeutic treatment of infectious and other diseases with mono and disaccharide based compounds.
AU2002309857A1 (en) * 2001-05-11 2002-12-03 Corixa Corporation Vaccines for the treatment of autoimmune disease
US11077179B2 (en) 2017-08-10 2021-08-03 Epicgenetics, Inc. Method for treating fibromyalgia and chronic fatigue syndrome

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
US5268170A (en) * 1986-09-09 1993-12-07 Yeda Research And Development Co., Ltd. Methods of treatment and diagnosis of autoimmune diseases, especially arthritic conditions
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
GB9203814D0 (en) * 1992-02-21 1992-04-08 Univ London Treatment of long term auto-immune conditions
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis

Also Published As

Publication number Publication date
WO2001010221A1 (en) 2001-02-15
CA2378285A1 (en) 2001-02-15
JP2003510335A (en) 2003-03-18
EP1206190A1 (en) 2002-05-22

Similar Documents

Publication Publication Date Title
IL158107A0 (en) Human papillomaviruses vaccine
AU1778001A (en) Human ex vivo immune system
AU5259100A (en) Medicament
IL196301A0 (en) Medicament for the treatment of hapatitis c
AUPQ302899A0 (en) Implants for the use in the treatment of aneurysmal disease
GB9929407D0 (en) Patient support
GB9915414D0 (en) Medical use
IL144981A0 (en) Treatment of autoimmune disease
AU7882900A (en) Hydrotherapy bed
AU1229101A (en) Cervical immobilization
AU3978700A (en) Medical use
GB9927757D0 (en) Treatment of autoimmune diseases
AU4556800A (en) Novel treatment
AU6896300A (en) Vaccines for the treatment of autoimmune disease
AU4416500A (en) Tomographic system
AU1043601A (en) Medical use
AU4456800A (en) Human hac3
AU1405001A (en) Treatment of diseases
AU3064800A (en) The therapeutic use of r-warfarin as anticoagulant
AU7999300A (en) Novel human phosphodiesterase zcytor13
AU5811600A (en) Vaccine
AU6234000A (en) Methods for treating autoimmune diseases
AU2002309857A1 (en) Vaccines for the treatment of autoimmune disease
AU7420800A (en) Medical use
AU2153801A (en) Idiotype vaccines

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase